Faculty |
|
Chair:
|
|
|
José Baselga, MD
Vall d’Hebron Hospital
Barcelona, Spain |
|
Martine Piccart-Gebhart, MD, PhD
Institute Jules Bordet
Brussels, Belgium |
| |
|
|
| Faculty: |
|
|
Ahmad Awada, MD, PhD
Institute Jules Bordet
Brussels, Belgium |
|
Robert Coleman, MD
Weston Park Hospital
Sheffield, United Kingdom |
| |
|
|
Javier Cortés, MD
Vall d’Hebron Hospital
Barcelona, Spain |
|
|
|
 Agenda |
|
A Roadmap to the Next Era in Breast Oncology: A Focus on Novel Agents and Strategies
prIME Oncology Satellite Symposium at the 7th European Breast Cancer Conference (EBCC)
|
| |
|
|
| Thursday, 25 March 2010 |
| |
|
|
| 19.15 |
|
Welcome and introduction
José Baselga, MD
Martine Piccart-Gebhart, MD, PhD
|
| |
|
|
| 19.20 |
|
The nab-technology platform: Targeted therapy in disguise?
Ahmad Awada, MD, PhD
Commentary: José Baselga, MD, and faculty panel
|
| |
|
|
| 19.40 |
|
|
Is there a novel chemotherapy on the horizon for progressive metastatic breast cancer?
Javier Cortés, MD
Commentary: Martine Piccart-Gebhart, MD, PhD, and faculty panel
|
|
| |
|
|
| 20.00 |
|
Multitargeted tyrosine kinase inhibition plus chemotherapy: A promising combination
José Baselga, MD
Commentary: Martine Piccart-Gebhart MD, PhD, and faculty panel
|
| |
|
|
| 20.20 |
|
Bone-targeted therapy: A unique and emerging addition to our armamentarium
Robert Coleman, MD
Commentary: José Baselga, MD, and faculty panel
|
| |
|
|
| 20.40 |
|
Concluding remarks
José Baselga, MD
Martine Piccart-Gebhart, MD, PhD
|
| |
|
|
|
|
